HOME >> BIOLOGY >> NEWS
Royal Society elects Tom Curran as Fellow

PHILADELPHIA Tom Curran, Ph.D., FRS, took his place alongside such distinguished scientists as Isaac Newton, Charles Darwin and Stephen Hawking with his election last week as a Fellow of the Royal Society of London for Improving Natural Knowledge. The 345-year-old Society is the national academy of science of the United Kingdom. The main criterion for election is scientific excellence.

Dr. Curran, a native of Scotland who enjoys dual, U.K./U.S. citizenship, is chairman of the department of developmental neurobiology at St. Jude Children's Research Hospital in Memphis, Tenn. He served the American Association for Cancer Research as president in 2000. His research focuses on molecular events that control the formation of the brain in mammals, and has shown that deregulated gene expression is a critical factor in the development and progression of cancer.

Early in his career, Dr. Curran discovered the fos oncogene and demonstrated its function in gene regulation. He then illustrated how the activity of nerves in the brain can affect the function of fos. This groundbreaking discovery helped open a new field of study key to explaining how changes in gene activity result in alterations in learning and memory. It was recognized by the AACR in 1993, when Dr. Curran received the AACR Award for Outstanding Achievement in Cancer Research, given annually to an accomplished young investigator in the field who is no more than 40 years old at the time the award is conferred.

His subsequent study of a gene called Reelin led to important new insights into how nerve cells in the developing brain migrate to their final locations to form orderly layers.

More recently, Dr. Curran has linked his interest in brain development to the studies of the molecular basis of cancer. Based on this work, he pioneered laboratory studies of a novel molecule called HhAntag to treat brain cancer without the need for traditional chemotherapy or radiation.


'"/>

Contact: Elizabeth Tait
tait@aacr.org
215-440-9300
American Association for Cancer Research
3-Jun-2005


Page: 1 2

Related biology news :

1. Top Canadian superstring theorist, Rob Myers of PI, inducted into Royal Society
2. Royal Museum to host improbable science event
3. Study in Royal Society journal on link between creativity and mating success
4. Study in Royal Society journal on first observation of giant squid in the wild
5. Study in Royal Society journal on possiblity of human organ regeneration
6. Study in Royal Society journal on worlds only horned rodent
7. Study in Royal Society journal on holly as an indicator of climate change
8. Study in Royal Society journal on heritability of female orgasm
9. UCLA physiologist elected to prestigious British Royal Society
10. Royal Society study on adaptability of fish to warming oceans
11. Study in Royal Society journal on sense of fairness in chimpanzees

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Royal Society elects Tom Curran Fellow

(Date:7/23/2014)... Ind. Spinach gave Popeye super strength, but it ... a group of scientists: the ability to convert sunlight ... physicists are part of an international group using spinach ... by which plants convert the sun,s energy into carbohydrates ... study are part of the most efficient system ever ...
(Date:7/23/2014)... , , , ... , , , , ... lifespan. The idea, they argue, would be to target the... , , ... , , , , ... , , , , , , , Medicine focuses almost entirely on ...
(Date:7/23/2014)... its grip is affecting more than the color of people,s ... a heat-loving amoeba commonly found in warm freshwater bodies, such ... made warmer than usual this year. , A 9-year-old Kansas ... after swimming in several area lakes. The amoeba enters the ... the brain. Nose plugs can lower the odds of this ...
Breaking Biology News(10 mins):Spinach could lead to alternative energy more powerful than Popeye 2Strategy proposed for preventing diseases of aging 2Strategy proposed for preventing diseases of aging 3Strategy proposed for preventing diseases of aging 4Strategy proposed for preventing diseases of aging 5Diseases of another kind 2
(Date:7/23/2014)... , July 23, 2014  Having the right people ... vital to accelerating business growth and achieving clinical and ... Association (AHA) Leadership Summit, July 20-22, 2014, in ... of hospital executives and healthcare experts discussing how partnerships ... Carrocino , President & Chief Executive Officer of Cape ...
(Date:7/23/2014)... StemGenex® , the leading resource for ... at improving the lives of patients dealing with degenerative ... disease. StemGenex believes that a commitment to the ... when providing care to patients with degenerative diseases. ... accessible to the millions of individuals currently living with ...
(Date:7/23/2014)... Iowa (PRWEB) July 23, 2014 DuPont ... the business as vice president of Agricultural Biotechnology (ABT), ... Biotechnology where he served most recently as president, chief ... biotechnology and business leadership in the seed and crop ... said Paul E. Schickler , president of DuPont ...
(Date:7/23/2014)... -- regulated information -- UCB today announced an important ... positive topline results from the latest Phase 3 ... to evaluate the efficacy and safety of ... compared to placebo, as adjunctive treatment in adult ... controlled despite treatment with one or two concomitant ...
Breaking Biology Technology:MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 3DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7
Cached News: